Oral Zinc in acne vulgaris (a double blind evaluation)
Agrawal, P.; Singh, P.K.; Pandey, S.S.; Singh, G.
Indian Journal of Dermatology Venereology and Leprology 51(1): 38-39
1985
ISSN/ISBN: 0973-3922 PMID: 28164874 Document Number: 261370
Document emailed within 1 workday
Related Documents
Cunliffe, W.J.; Burke, B.; Dodman, B.; Gould, D.J. 1979: A double-blind trial of a zinc sulphate/citrate complex and tetracycline in the treatment of acne vulgaris British Journal of Dermatology 101(3): 321-325Stoughton, R.B.; Cornell, R.C.; Gange, R.W.; Walter, J.F. 1980: Double-blind comparison of topical 1 percent clindamycin phosphate (Cleocin T) and oral tetracycline 500 mg/day in the treatment of acne vulgaris Cutis 26(4): 424-425; 429
Ghorpade, A.; Reddy, B.S.N.; Rizvi, S.N.A. 1982: Plasma Zinc Levels and the Effect of Oral Zinc in Acne Vulgaris Indian Journal of Dermatology Venereology and Leprology 48(3): 129-137
Linss, G.; Schuster, G.; Freier, B.; Schielinsky, C.; Bach, W.; Lenski, K. 1981: Investigation of the bioelements zinc, copper and magnesium in acne-patients. a therapeutic study with zinc sulfate in a double-blind trial Dermatologische Monatschrift 167(4): 228-233
Kanaar, P.; Zelvelder, W.G.; van Delden, J.; van de Staak, W.J. 1972: Tetracycline treatment of acne vulgaris with special reference to the methodical respects of a double blind study Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 23(8): 345-349
Eichenfield, L.F.; Jarratt, M.; Schlessinger, J.; Kempers, S.; Manna, V.; Hwa, J.; Liu, Y.; Graeber, M.; Albrecht, L.; Arthur, E.; Barba, A.; Barber, K.; Bond, M.; Bucko, A.; Clark, S.; Cornelison, R.; Dinehart, S.; Dinulos, J.; Draelos, Z.; Fisher, G.; Glazer, S.; Glenn, M.; Del Rey, M.; Haber, R.; Hamzavi, I.; Harris, H.; Jarratt, M.; Landells, I.; Lee, M.; Leonardi, C.; Loebl, A.; Lynde, C.; Matheson, R.; Moore, A.; Mraz, S.; Papp, K.; Pariser, D.; Rafal, E.; Smith, S.; Stough, D.; Swinehart, J.; Toole, J.; Tyring, S.; Vender, R.; Wasel, N.; Westmoreland, P.; Wiltz, H.; Wilson, D.; Bruce, S.; Carey, W.; Cook-Bolden, F.; Davidson, L.; Eichenfield, L.; Fahrner, L.; Fowler, J.; Gillum, P.; Gold, M.; Greenstein, D.; Heller, G.; Horowitz, D.; 2010: Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies Journal of Drugs in Dermatology: Jdd 9(6): 639-646
Draelos, Z.D.; Rodriguez, D.A.; Kempers, S.E.; Bruce, S.; Peredo, M.I.; Downie, J.; Chang-Lin, J.-E.; Berk, D.R.; Ruan, S.; Kaoukhov, A. 2017: Treatment Response with Once-Daily Topical Dapsone Gel, 7.5% for Acne Vulgaris: Subgroup Analysis of Pooled Data from two Randomized, Double-Blind Stu Journal of Drugs in Dermatology: Jdd 16(6): 591-598
Feldman, S.R.; Werner, C.P.; Alió Saenz, A.B. 2013: The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle-controlled, double-blind studies Journal of Drugs in Dermatology: Jdd 12(4): 438-446
Webster, G.F.; Guenther, L.; Poulin, Y.P.; Solomon, B.A.; Loven, K.; Lee, J. 2002: A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris Cutis 69(2 Suppl): 4-11
Shalita, A.; Miller, B.; Menter, A.; Abramovits, W.; Loven, K.; Kakita, L. 2005: Tazarotene cream versus adapalene cream in the treatment of facial acne vulgaris: a multicenter, double-blind, randomized, parallel-group study Journal of Drugs in Dermatology: Jdd 4(2): 153-158
Tanghetti, E.; Abramovits, W.; Solomon, B.; Loven, K.; Shalita, A. 2006: Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial Journal of Drugs in Dermatology: Jdd 5(3): 256-261
Palli, M.B.A.; Reyes-Habito, C.M.; Lima, X.T.; Kimball, A.B. 2013: A single-center, randomized double-blind, parallel-group study to examine the safety and efficacy of 3mg drospirenone/0.02 mg ethinyl estradiol compared with placebo in the treatment of moderate truncal acne vulgaris Journal of Drugs in Dermatology: Jdd 12(6): 633-637
Eichenfield, L.F.; Alió Sáenz, A.B. 2011: Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study Journal of Drugs in Dermatology: Jdd 10(12): 1382-1396
Perez, M.; Aspiolea, F.; De Moragas, J.M. 1987: Comparative double-blind study of topical clindamycin phosphate and oral tetracycline in the treatment of acne Medicina Cutanea Ibero-Latino-Americana 15(3): 173-177
Badii, A.; Nekouei, N.; Fazilati, M.; Shahedi, M.; Badiei, S. 2012: Effect of Consuming Zinc-fortified Bread on Serum Zinc and Iron Status of Zinc-deficient Women: a Double Blind, Randomized Clinical Trial International Journal of Preventive Medicine 3(Suppl 1): S124-S130
Jemec, G.B.E.; Linneberg, A.; Nielsen, N.Henrik.; Frølund, L.; Madsen, F.; Jørgensen, T. 2002: Have oral contraceptives reduced the prevalence of acne? a population-based study of acne vulgaris, tobacco smoking and oral contraceptives Dermatology 204(3): 179-184
Plewig, G.; Cunliffe, W.J.; Binder, N.; Höschen, K. 2009: Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase IIi trial Contraception 80(1): 25-33
Fitzherbert, J.C. 1976: Acne vulgaris--zinc deficiency Medical Journal of Australia 2(7): 273
Patel, A.B.; Dhande, L.A.; Rawat, M.S. 2005: Therapeutic evaluation of zinc and copper supplementation in acute diarrhea in children: double blind randomized trial Indian Pediatrics 42(5): 433-442
Vahlquist, A.; Michaëlsson, G.; Juhlin, L. 1978: Acne treatment with oral zinc and vitamin A: effects on the serum levels of zinc and retinol binding protein (RBP) Acta Dermato-Venereologica 58(5): 437-442